Cell-based gene therapies in oncology: Case study of the challenges of CAR-T therapy
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Presentation
- By: KOLESAR, Jill (University of Kentucky, USA)
CAR T therapy is a type of treatment in which a patient's T cells are removed via apheresis, sent to a processing laboratory and a chimeric antigen receptor (CAR) is introduced into the T cells, which allows the CAR T cell to identify and eliminate both malignant and normal cells that express a given antigen. While multiple tumor antigens are.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.